台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣東洋藥品工業股份有限公司 台北市南港區園區街3之1號3樓 (11821341) - pemetrexed disodium 2.5 hydrate - 注射劑 - pemetrexed disodium 2.5 hydrate (1004002420) equal to pemetrexed 25mgmg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.與pembrolizumab及含鉑化學療法併用，做為轉移性，不具有egfr或alk腫瘤基因異常之非鱗狀非小細胞肺癌的第一線治療藥物。5.與cisplatin併用於治療惡性肋膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣阿斯特捷利康股份有限公司 台北市大安區敦化南路二段207號21樓 (16440975) - naproxen;;esomeprazole magnesium trihydrate - 緩釋膜衣錠 - naproxen (2808402000) mg; esomeprazole magnesium trihydrate (5640002910) (corresp. to esomeprazole 20mg )mg - naproxen and esomeprazole - 適用於緩解骨關節炎、類風性關節炎、及僵直性脊椎炎之症狀與徵象，減少有發生nsaid治療相關之胃潰瘍及/或十二指腸潰瘍風險的病人發生nsaid治療相關之胃潰瘍的風險。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610) - tepotinib hydrochloride hydrate - 膜衣錠 - tepotinib hydrochloride hydrate (1013009200) (equivalent to 225 mg tepotinib)mg - tepotinib - 適用於治療帶有導致間質上皮轉化因子外顯子14跳讀式突變(met exon 14 skipping mutation)的轉移性之非小細胞肺癌(nsclc)成人病人。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - isoleucine;;leucine;;lysine hcl;;methionine;;threonine;;valine;;arginine;;histidine hcl monohydrate;;alanine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;aspartic acid;;glutamic acid;;proline;;serine;;phenylalanine;;tryptophan;;glucose monohydrate;;sodium hydroxide;;sodium chloride;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;sodium dihydrogen phosphate dihydrate;;potassium acetate;;magnesium acetate tetrahydrate;;calcium chloride dihydrate;;zinc acetate dihydrate;;triglycerides medium chain;;soybean oil ( eq to soya bean oil) - 注射劑 - potassium acetate (4008000100) mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium acetate tetrahydrate (4012001450) mg; sodium chloride (4012002100) mg; glucose monohydrate (4020000760) (eq. to anhydrous glucose 64.0mg)mg; soybean oil ( eq to soya bean oil) (4020001600) mg; alanine (4020100200) mg; arginine (4020100300) mg; aspartic acid (4020100400) mg; glutamic acid (4020100700) mg; histidine hcl monohydrate (4020100915) (eq. to histidine 1.0 mg)mg; isoleucine (4020101000) mg; leucine (4020101200) mg; lysine hcl (4020101310) (eq. to lysine 1.81mg)mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; sodium dihydrogen phosphate dihydrate (5612002611) mg; triglycerides medium chain (5640001102) mg; zinc acetate dihydrate (9200010550) ug; sodium hydroxide (9600028200) mg - combinations - 患者在無法使用或不適宜或不充足使用口服，腸道營養劑時，作為靜脈營養治療之熱量、必需脂肪酸、胺基酸、電解質及液體的補充。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - glucose anhydrous;;calcium chloride dihydrate;;l-isoleucine;;l-leucine;;lysine l- (hcl);;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;arginine l- (monoglutamate);;histidine l- (hcl monohydrate);;l-alanine;;l-aspartic acid;;glutamic acid l-;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-proline;;l-serine;;magnesium acetate tetrahydrate;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium dihydrogen phosphate;;potassium hydroxide;;sodium hydroxide - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 1.63mg; calcium chloride dihydrate (4012000350) 0.6mg; magnesium acetate tetrahydrate (4012001450) 1.08mg; glucose anhydrous (4020000750) 240mg; l-alanine (4020100202) 8.49mg; l-aspartic acid (4020100402) 2.63mg; glutamic acid l- (4020100702) 6.14mg; l-isoleucine (4020101002) 4.11mg; l-leucine (4020101202) 5.48mg; l-methionine (4020101502) 3.42mg; l-phenylalanine (4020101702) 6.15mg; l-proline (4020101802) 5.95mg; l-serine (4020101902) 5.25mg; l-threonine (4020102002) 3.18mg; l-tryptophan (4020102102) 1mg; l-valine (4020102302) 4.54mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 2.89mg; arginine l- (monoglutamate) (4020109342) 4.73mg; histidine l- (hcl monohydrate) (4020109922) 2.19mg; lysine l- (hcl) (4020191312) 3.98mg; potassium dihydrogen phosphate (5612001920) 2.00mg; potassium hydroxide (9600024100) 0.62mg; sodium hydroxide (9600028200) 1.14mg - combinations - 無法經口服攝食或腸道吸收營養、功能不全有禁忌症時，對中等到嚴重異化作用狀態的病人的靜脈營養提供氨基酸、 葡萄糖、電解質和液體。欣保康優靜脈營養輸注液適用於成人和 2 到17 歲的兒童。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - sodium chloride;;sodium lactate solution;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;dextrose monohydrate - 透析用液劑 - sodium lactate solution (4008000980) gm; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; sodium chloride (4012002100) gm; dextrose monohydrate (4020000570) eq.to dextrose anhydrous 22.73 gmgm - isotonic solutions - 腹膜透析

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - sodium chloride;;sodium lactate solution;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;dextrose monohydrate - 透析用液劑 - sodium lactate solution (4008000980) gm; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; sodium chloride (4012002100) gm; dextrose monohydrate (4020000570) 46.75gm - peritoneal dialytics - 腹膜透析

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯醫藥股份有限公司 台北市內湖區瑞湖街58號7樓 (16437417) - sodium chloride;;sodium lactate solution;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;dextrose (monohydrate) - 透析用液劑 - sodium lactate solution (4008000980) 7.847gm; calcium chloride dihydrate (4012000350) 0.2573gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) 0.1017gm; sodium chloride (4012002100) 5.786gm; dextrose (monohydrate) (4020009570) (15.00g) 16.50gm - peritoneal dialytics - 腹膜透析

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;glucose anhydrous;;lactic acid;;sodium chloride;;sodium bicarbonate ( eq to sodium hydrogen carbonate);;potassium chloride - 透析用液劑 - 主成分 () ; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; glucose anhydrous (4020000750) gm; lactic acid (9200005300) gm; sodium bicarbonate ( eq to sodium hydrogen carbonate) (4008000700) gm; potassium chloride (4012001800) gm; sodium chloride (4012002100) gm - hemodialytics, concentrates - 連續性血液過濾或連續性血液透析過濾所使用的補充液,連續性血液透析或連續性血液透析過濾所使用之透析液。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;glucose anhydrous;;lactic acid;;sodium chloride;;sodium bicarbonate ( eq to sodium hydrogen carbonate);;potassium chloride - 透析用液劑 - 主成分 () ; calcium chloride dihydrate (4012000350) gm; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) gm; glucose anhydrous (4020000750) gm; lactic acid (9200005300) gm; sodium bicarbonate ( eq to sodium hydrogen carbonate) (4008000700) gm; potassium chloride (4012001800) gm; sodium chloride (4012002100) gm - hemodialytics, concentrates - 連續性血液過濾或連續性血液透析過濾所使用的補充液,連續性血液透析或連續性血液透析過濾所使用之透析液。